Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis

European Journal of Clinical Pharmacology

Volumn 52, Issue 4, 1997, Pages 269-275

  Hoebe, C ^a   De Munter, J ^b   Thijs, C ^c  

^a Reg Pub Health Institute Heerlen   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adverse reactions; Compliance; Malaria prophylaxis; Mefloquine; Proguanil

Indexed keywords

MEFLOQUINE; PROGUANIL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; NAUSEA; NIGHTMARE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; SYMPTOM; TRAVEL; VERTIGO; VOMITING;

ADULT; AGED; ANTIMALARIALS; CHLOROGUANIDE; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALARIA; MALE; MEFLOQUINE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NETHERLANDS; PATIENT COMPLIANCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TRAVEL; TREATMENT REFUSAL;

EID: 0030841782     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050288     Document Type: Article

References (33)

1. Reynolds JEF (ed) (1993) Martindale, the extra pharmacopoeia, 13th edn. Pharmaceutical Press, London, pp 402-405
2. Kuy A vd (ed) (1996) Farmacotherapeutisch Kompas: medische farmaceutische voorlichting, 13e editie. Centrale Medische Pharmaceutische Commissie van de Ziekenfondsraad, Amstelveen, pp 694-695
3. Basco LK, Calvert L, Raeside F (1994) Confused malaria chemoprophylaxis. (letter) Lancet 343: 550-551
4. Miettinen OS, Caro JJ (1989) Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol 42: 325-331
5. Nurminen M (1992) Assessment of excess risks in case-base studies. J Clin Epidemiol 45: 1081-1092
6. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19: 251-253
7. Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P, Phillips-Howard P, Nevill C, Stürchler D (1993) Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 341: 1299-1303
8. Steffen R, Heusser R, Machler R, Bruppacher R, Neaf U, Chen D, Hofmann AM, Somaini B (1990) Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull World Health Organ 68: 313-322
9. Steffen R, Fuchs E, Dunlop J, Naef U, Chen D (1991) Mefloquine: Safety and efficacy in European tourists visiting East Africa. (Abstract) J Clin Pharmacoepidemiol 5: 187-188
10. Vuurman EFPM, Muntjewerff ND, Uiterwijk MMC, Van Veggel LMA, Crevoisier C, Haglund L, Kinzig M, O'Hanlon JF (1996) Effects of Mefloquine alone and with alcohol on psychomotor and driving performance. Eur J Clin Pharm 50: 475-482
11. Eamsila C, Singharaj P, Yooyen P, Chatnugrob P, Ayuthya ANN, Webster HK, Laserre R, Mittelholzer ML, Stürchler D (1993) Prevention of plasmodium falciparum malaria by Fansimef® and Lariam® in the northeastern part of Thailand. Southeast Asian J Trop Med Public Health 24: 672-676
12. Sanchez JL, DeFraites RF, Sharp TW, Hanson RK (1993) Mefloquine or doxycycline prophylaxis in US troops in Somalia. Lancet 341: 1021-1022
13. Lobel HO, Bernard KW, Williams SL, Highlower AW, Patehen LC, Campbell CC (1991) Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. JAMA 265: 361-364
14. Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L (1993) Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 44: 257-265
15. Boudreau EF, Pang LW, Chaikummao S, Witayarut C (1991) Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand. Southeast Asian J Trop Med Public Health 22: 183-189
16. Arthur JD, Echeverria P, Shanks GD, Karwacki J, Bodhidatta L, Brown JE (1990) A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis. Am J Trop Med Hyg 43: 608-613
17. Arthur JD, Shanks GD, Echeverria P (1990) Mefloquine prophylaxis. Lancet 335: 972
18. Korzarsky P, Eaton M (1993) Use of mefloquine for malarial chemoprophylaxis in its first year of availability in the United States. Clin Infect Dis 16: 185-186
19. Rombo L, Angel VH, Friman G, Hellgren U, Mittelholzer ML, Strurchler D (1993) Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in non-immune volunteers. Trop Med Parasitol 44: 254-256
20. Kollaritsch H, Stemberger H, Mailer H, Kremsner P, Kollaritsch R, Leimer R, Wiedermann G (1988) Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef®): results of a double blind field trial versus chloroquine in Nigeria. Trans R Soc Trop Med Hyg 82: 524-529
21. Kamolratanakul P, Viputsiri O, Dhanamun B, Hirunabut S, Mekmasin A, Thongsawat P (1989) The effectiveness of chemoprophylaxis against malaria for non-immune migrant workers in eastern Thailand. Trans R Soc Trop Med Hyg 83: 313-315
22. Reisinger EC, Horstmann RD, Dietrich M (1989) Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria. Trans R Soc Trop Med Hyg 83: 474-477
23. Nosten F, Karbwang J, White NJ, Honeymoon, Na Bangchang K, Bunnag D, Harinasuta T (1990) Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Br J Clin Pharmac 30: 79-85
24. De Souza JM, Sheth UK, De Oliveira RMG, Gomes AT, Cavalcante EQ (1985) A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. Bull WHO 63: 611-615
25. Rieckmann KH, Yeo AET, Davis DR, Hutton DC, Wheatley PF. Simpson R (1993) Recent military experience with malaria chemoprophylaxis. Med J Aust 158: 446-449
26. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC (1993) Long-term malaria prophylaxis with weekly mefloquine. Lancet 341: 848-851
27. Suriyamongkol V, Timsaad S, Shanks GD (1991) Mefloquine chemoprophylaxis of soldiers on the Thai-Cambodian border. Southeast Asian J Trop Med Public Health 22: 515-518
28. Croft A (1995) Toxity of mefloquine is similar to that of other chemoprophylaxis. (letter) BMJ 311: 191
29. Nosten F, Ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, Boudreau E, Bunnag, D, White NJ (1994) Mefloquine prophylaxis prevents malaria during pregnancy: A double-blind, placebo-controlled study. J Infect Dis 169: 595-603
30. Bunnag D, Malikul S, Chittamas S, Chindanond D, Harinasuta T, Fernex M, Mittelholzer ML, Kristiansen S, Sturchler D (1993) Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial. Southeast Asian J Trop Med Public Health 23: 777-782
31. Salako LA, Adio RA, Walker O, Sowunmi A, Strurchler D, Mittelholzer ML, Reber-Liske R, Dickschat U (1992) Mefloquine-sulphadoxine-pyrimethamine (Fansimef. Röche) in the prophylaxis of plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Ann Trop Med Parasit 86: 575-581
32. Karbwang J, Bunnag D, Breckenridge AM, Back DJ (1987) The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects. Eur J Pharmacol 32: 173-177
33. Tin F, Hlaing N, Lasserre R (1982) Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. Bull WHO 60: 913-917